COMMUNIQUÉS West-GlobeNewswire

Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation

07/11/2017 - 07:30

ORION CORPORATION PRESS RELEASE 7 NOVEMBER 2017 at 8.30 EET Professor Heikki Joensuu has been appointed Vice President of Therapy area Oncology, R&D in Orion Corporation Professor Heikki Joensuu, M.D., Ph.D., has [...]

Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage

07/11/2017 - 07:15

Structural joint damage in psoriatic arthritis (PsA) patients taking Cosentyx ® (secukinumab) was inhibited at 24 weeks versus placebo in all arms of the study[1] PsA can lead to reduced mobility and irreversible joint [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

07/11/2017 - 07:10

REGULATED INFORMATION GHENT, Belgium, 7 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

07/11/2017 - 07:05

REGULATED INFORMATION GHENT, Belgium, 7 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

CORRECTION OF PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

07/11/2017 - 07:00

REGULATED INFORMATION GHENT, Belgium, 7 November 2017 - Ablynx [Euronext Brussels and Nasdaq: ABLX] announced on 3 November 2017, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication [...]

Todd Bazemore Steps Down from Role as Chief Operating Officer of Santhera's US Subsidiary

06/11/2017 - 20:36

Liestal, Switzerland, November 6, 2017 - Santhera Pharmaceuticals (SIX: SANN) announces that Todd Bazemore resigns his role as Chief Operating Officer of Santhera Pharmaceuticals (USA) Inc. and member of executive [...]

VALNEVA : Déclaration d'actions et de droits de vote octobre 2017

06/11/2017 - 18:00

VALNEVA Déclaration d'actions et de droits de vote - OCTOBRE 2017 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]

Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2017

06/11/2017 - 18:00

Nombre total de droits de vote et d'actions composant le capital social au 31 octobre 2017 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France [...]

Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2017

06/11/2017 - 18:00

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2017 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]

Le MABp1 de XBiotech fera l'objet d'une présentation orale lors des séances scientifiques de l'American Heart Association

06/11/2017 - 17:28

Présentation pour discuter des nouveaux résultats sur MABp1 dans la prévention de la thrombose coronaire AUSTIN, Texas, le 3 novembre 2017 (GLOBE NEWSWIRE) - XBiotech Inc. (NASDAQ : XBIT) a annoncé aujourd'hui que la [...]

Ossur Hf : Transactions in relation to share buyback program

06/11/2017 - 17:00

Announcement from Össur hf. No. 80/2017 Reykjavík, 6 November 2017 On 15 August 2017, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2017. The purpose of the share buyback program is to [...]

Acarix AB to seek new CEO

06/11/2017 - 14:40

Press release Malmö, November 6, 2017 Acarix AB to seek new CEO Acarix AB (publ) ("Acarix") announced today that CEO Søren Rysholt Christiansen has resigned on 6 Nov. 2017, with the effect to leave the company at the [...]

Adaptimmune marks Official Opening of U.K. Headquarters

06/11/2017 - 14:15

Flagship Facility is new Base for U.K. Research and Development Operations PHILADELPHIA and OXFORD, U.K., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat [...]

Novo Nordisk A/S - Share repurchase programme

06/11/2017 - 13:31

Bagsværd, Denmark, 6 November 2017 - On 1 November 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April [...]

Minerva Neurosciences Reports Third Quarter 2017 Financial Results and Business Updates

06/11/2017 - 13:30

WALTHAM, Mass., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) [...]

Summit Therapeutics Announces Revenue Sharing Agreement with Wellcome Trust

06/11/2017 - 13:00

Summit Therapeutics plc ("Summit" or the "Company") SUMMIT ANNOUNCES SIGNING OF REVENUE SHARING AGREEMENT WITH THE WELLCOME TRUST FOR CDI ANTIBIOTIC RIDINILAZOLE Entering revenue share in accordance with terms of prior [...]

iTeos Therapeutics to Present New Data at Upcoming 2017 SITC Annual Meeting

06/11/2017 - 13:00

iTeos Therapeutics to Present New Data at Upcoming 2017 SITC Annual Meeting Presentations to highlight new preclinical results for A 2A antagonist and TIGIT antibody programs Gosselies, Belgium - November 6, 2017 - [...]

Amer Sports Corporation: Managers' transactions

06/11/2017 - 13:00

Amer Sports Corporation MANAGERS' TRANSACTIONS November 6, 2017 at 2:00 p.m. Amer Sports Corporation: Managers' transactions Person subject to the notification requirement Name: Sälzer, Bruno Position: Member of the [...]

PCI Biotech to present at BIO-Europe 2017

06/11/2017 - 10:32

Oslo, Norway, November 6, 2017 PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present at BIO-Europe 2017 [...]